Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totaling 126,538 shares, a drop of 68.2% from the April 30th total of 397,818 shares. Based on an average daily trading volume, of 471,811 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.8% of the company’s stock are short sold.
Azitra Stock Performance
Azitra stock opened at $0.23 on Monday. The stock has a 50-day moving average of $0.23 and a two-hundred day moving average of $0.25. Azitra has a one year low of $0.10 and a one year high of $2.40.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.24). As a group, sell-side analysts forecast that Azitra will post -0.25 earnings per share for the current year.
About Azitra
Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.
The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.
Read More
- Five stocks we like better than Azitra
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
